Digest Network Come funziona
Network
/
Società
Dr
Non verificato

Drug Farm

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

13 comunicati stampa

Guarda tutti i comunicati
01/09/2026
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Ottica
Salute
Medicina - Varie
Drug Farm Presents Positive Ophthalmologic and Systemic Findings from International Phase 1b Study of First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at APVRS 2026
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
13/07/2026
Tecnica
Finanza
Biotecnologia
Medicina - Varie
Associazioni/Professionisti
Farmaceutica
Salute
Drug Farm Completes First Closing of $55 Million Series D Financing to Advance Clinical and Preclinical Development Pipeline
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
07/05/2026
Industria
Eventi
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Cardiologia
Farmaceutica
Salute
Ottica
Drug Farm to Present Ophthalmologic and CNS Findings from Phase 1b Study of First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at ARVO 2026
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
17/04/2026
Eventi
Industria
Sanità
Scienza
Farmaceutica
Ottica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Drug Farm to Present Positive Phase 1b Data for First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at IMMUNOLOGY2026™
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
26/03/2026
Industria
Cardiologia
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Ottica
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Drug Farm Announces U.S. FDA Orphan Drug Designation for DF-003 for the Treatment of ROSAH Syndrome
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
05/03/2026
Industria
Scienza
HIV, AIDS e malattie autoimmuni
Igiene alimentare
Biotecnologia
Medicina - Varie
Cardiologia
Farmaceutica
Salute
Drug Farm Announces FDA Acceptance of DF-003 into Rare Disease Evidence Principles Process for ROSAH Syndrome
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
27/01/2026
Cardiologia
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Ottica
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Industria
Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
23/09/2025
Mercato del lavoro
Industria
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Cardiologia
Salute
Farmaceutica
Oncologia
Drug Farm Announces Agreement with Cincinnati Children’s Hospital Medical Center to Explore ALPK1 Inhibitor, DF-003 as a Potential Treatment for Heart Disease and Blood Cancers Driven by Clonal Hematopoiesis
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
09/09/2025
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Industria
Drug Farm Announces Publication in Nature Communications Describing the Discovery and Preclinical Characterization of First-in-Class ALPK1 inhibitor, DF-003
Fonte
Drug Farm
Emittente
Business Wire
1.00
0
04/08/2025
Scienza
Farmaceutica
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Industria
Drug Farm Announces First Patients Dosed in Phase 1b Clinical Trial Evaluating ALPK1 Inhibitor, DF-003 in ROSAH Syndrome
Fonte
Drug Farm
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0